461 related articles for article (PubMed ID: 34898315)
21. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
[TBL] [Abstract][Full Text] [Related]
22. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
[TBL] [Abstract][Full Text] [Related]
23. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
[TBL] [Abstract][Full Text] [Related]
24. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.
De Rose F; Fogliata A; Franceschini D; Navarria P; Villa E; Iftode C; D'Agostino G; Cozzi L; Lobefalo F; Mancosu P; Tomatis S; Scorsetti M
Radiat Oncol; 2016 Sep; 11(1):120. PubMed ID: 27639373
[TBL] [Abstract][Full Text] [Related]
26. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
[TBL] [Abstract][Full Text] [Related]
28. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
[TBL] [Abstract][Full Text] [Related]
29. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.
Dicuonzo S; Leonardi MC; Raimondi S; Corrao G; Bagnardi V; Gerardi MA; Morra A; Zerella MA; Zaffaroni M; Pansini F; Cattani F; Luraschi R; Fodor C; Veronesi P; Orecchia R; Rojas DP; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Jul; 23(7):1415-1428. PubMed ID: 33537865
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Radiation Induced Pneumonitis and Pericarditis in Patients Undergoing Breast Conservative Treatment Using Hypofractionated Simultaneous Integrated Boost Technique.
Sundaramoorthy S; Karunanidhi G; Pal P; C SV; Radhakrishnan H
Gulf J Oncolog; 2024 May; 1(45):15-29. PubMed ID: 38774929
[TBL] [Abstract][Full Text] [Related]
31. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
[TBL] [Abstract][Full Text] [Related]
32. Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.
Freedman GM; Anderson PR; Bleicher RJ; Litwin S; Li T; Swaby RF; Ma CM; Li J; Sigurdson ER; Watkins-Bruner D; Morrow M; Goldstein LJ
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):888-93. PubMed ID: 22580118
[TBL] [Abstract][Full Text] [Related]
33. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
[TBL] [Abstract][Full Text] [Related]
34. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
Nozaki M; Kagami Y; Machida R; Nakamura K; Ito Y; Nishimura Y; Teshima T; Saito Y; Nagata Y; Matsumoto Y; Akimoto T; Hiraoka M;
Jpn J Clin Oncol; 2021 May; 51(6):865-872. PubMed ID: 33728450
[TBL] [Abstract][Full Text] [Related]
35. Survival Outcomes of Post-mastectomy Breast Cancer Patients Treated with Hypofractionated Radiation Treatment Compared to Conventional Fractionation -a Retrospective Cohort Study.
Raveendran C; Meloot SS; Yadev I
Gulf J Oncolog; 2023 May; 1(42):26-34. PubMed ID: 37283257
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.
Arcadipane F; Franco P; De Colle C; Rondi N; Di Muzio J; Pelle E; Martini S; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ragona R; Ricardi U
Med Oncol; 2016 Oct; 33(10):108. PubMed ID: 27573380
[TBL] [Abstract][Full Text] [Related]
37. A Comparison Between Sequential Conventional and Hypofractionated Boost Following Whole-Breast Radiotherapy: A Propensity Score-Matched Analysis.
Rajan J; Kr R; Sara George P; Arjunan A; Balakrishnan P; Augustine P; Sarah Mathew B
Cureus; 2023 Oct; 15(10):e46913. PubMed ID: 37954819
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.
Zhong L; Chen L; Lv S; Li Q; Chen G; Luo W; Zhou P; Li G
Radiat Oncol; 2019 Jun; 14(1):104. PubMed ID: 31196126
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
[TBL] [Abstract][Full Text] [Related]
40. Significance of Hypofractionated Radiotherapy in Postoperative Irradiation for Breast Cancer: An Asian Multi-institutional Prospective Study.
Okonogi N; Kono S; Karasawa K; Banu PA; Xu X; Erawati D; Adylkhanov T; Jang WI; E Y; Calaguas MJ; Thephamongkhol K; Dung TA; Ng WNP; Kato S;
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):463-471. PubMed ID: 37179216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
